Lv6
1850 积分 2022-04-14 加入
维得利珠单抗对炎症性肠病患者的短期疗效及安全性
2个月前
已完结
维得利珠单抗对炎症性肠病患者的短期疗效及安全性
2个月前
已关闭
炎症性肠病患者应用生物制剂和小分子制剂发生潜伏结核感染再激活风险现状和应对
2个月前
已关闭
P-179 Safety, Pharmacokinetics and Pharmacodynamics of Etrasimod (APD334), an Oral Selective S1P Receptor Modulator, After Dose-Escalation, in Healthy Volunteers
2个月前
已关闭
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
3个月前
已完结
A tale of two diseases: The history of inflammatory bowel disease
4个月前
已完结
An Aeromonas variant that produces aerolysin promotes susceptibility to ulcerative colitis
4个月前
已完结
Behçet's syndrome
4个月前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
4个月前
已完结
皖公网安备34019202002308
